• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坏死性凋亡相关长链非编码 RNA 特征可预测子宫内膜癌患者的预后

Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer.

机构信息

Shandong University of Traditional Chinese Medicine, Jinan, 250014, Shandong, China.

Department of Orthopedic Surgery, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.

出版信息

Reprod Sci. 2023 Feb;30(2):576-589. doi: 10.1007/s43032-022-01023-9. Epub 2022 Jul 19.

DOI:10.1007/s43032-022-01023-9
PMID:35854199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9988759/
Abstract

Necroptosis is one of the common modes of apoptosis, and it has an intrinsic association with cancer prognosis. However, the role of the necroptosis-related long non-coding RNA LncRNA (NRLncRNAs) in uterine corpora endometrial cancer (UCEC) has not yet been fully elucidated at present. Therefore, the present study is designed to investigate the potential prognostic value of necroptosis-related LncRNAs in UCEC. In the present study, the expression profiles and clinical data of UCEC patients were downloaded from TCGA database to identify the differentially expressed NRLncRNAs associated with overall survival. A LncRNA risk model was constructed via Cox regression analysis, and its prognostic value was evaluated. We have also further evaluated the relationships between the LncRNA features and the related cellular function, related pathways, immune status, and immune checkpoints m6A-related genes. Seven signatures, including PCAT19, CDKN2B-AS1, LINC01936, LINC02178, BMPR1B-DT, LINC00237, and TRPM2-AS, were established to assess the overall survival (OS) of the UCEC in the present study. Survival analysis and ROC curves indicated that the correlated signature has good predictable performance. The normogram could accurately predict the overall survival of the patients with an excellent clinical practical value. Enrichment analysis of gene sets indicated that risk signals were enriched in several immune-related pathways. In addition, the risk characteristics were significantly correlated with immune cells, immune function, immune cell infiltration, immune checkpoints, and some m6A-related genes. This study has identified seven necroptosis-related LncRNA signatures for the first time, providing a valuable basis for a more accurate prognostic prediction of UCEC.

摘要

细胞坏死是细胞凋亡的一种常见方式,它与癌症的预后有内在的关联。然而,目前尚未完全阐明与细胞坏死相关的长链非编码 RNA(LncRNA)在子宫内膜癌(UCEC)中的作用。因此,本研究旨在探讨与细胞坏死相关的 LncRNAs 在 UCEC 中的潜在预后价值。

在本研究中,从 TCGA 数据库中下载了 UCEC 患者的表达谱和临床数据,以确定与总生存期相关的差异表达的与细胞坏死相关的 LncRNA。通过 Cox 回归分析构建了 LncRNA 风险模型,并评估了其预后价值。我们还进一步评估了 LncRNA 特征与相关细胞功能、相关途径、免疫状态和免疫检查点 m6A 相关基因之间的关系。

在本研究中,建立了七个特征,包括 PCAT19、CDKN2B-AS1、LINC01936、LINC02178、BMPR1B-DT、LINC00237 和 TRPM2-AS,以评估 UCEC 的总生存期(OS)。生存分析和 ROC 曲线表明,相关特征具有良好的预测性能。列线图可以准确预测患者的总生存期,具有极好的临床实用价值。基因集的富集分析表明,风险信号富集在几个免疫相关途径中。此外,风险特征与免疫细胞、免疫功能、免疫细胞浸润、免疫检查点和一些 m6A 相关基因显著相关。

本研究首次鉴定了七个与细胞坏死相关的 LncRNA 特征,为更准确地预测 UCEC 的预后提供了有价值的依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/a688d8931bd9/43032_2022_1023_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/4fac7d841def/43032_2022_1023_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/ee7f594913e0/43032_2022_1023_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/29d33611993b/43032_2022_1023_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/4732c5e0d8f2/43032_2022_1023_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/1eb6ed51e041/43032_2022_1023_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/4c2d0bfc3820/43032_2022_1023_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/0feeb4c36679/43032_2022_1023_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/a688d8931bd9/43032_2022_1023_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/4fac7d841def/43032_2022_1023_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/ee7f594913e0/43032_2022_1023_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/29d33611993b/43032_2022_1023_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/4732c5e0d8f2/43032_2022_1023_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/1eb6ed51e041/43032_2022_1023_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/4c2d0bfc3820/43032_2022_1023_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/0feeb4c36679/43032_2022_1023_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3306/9988759/a688d8931bd9/43032_2022_1023_Fig8_HTML.jpg

相似文献

1
Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer.坏死性凋亡相关长链非编码 RNA 特征可预测子宫内膜癌患者的预后
Reprod Sci. 2023 Feb;30(2):576-589. doi: 10.1007/s43032-022-01023-9. Epub 2022 Jul 19.
2
Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database.基于 TCGA 数据库的五个 m6A 相关 lncRNA 基因作为子宫内膜癌预后标志物的鉴定。
J Immunol Res. 2022 May 4;2022:2547029. doi: 10.1155/2022/2547029. eCollection 2022.
3
Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.建立与细胞坏死相关的子宫体子宫内膜癌预后模型。
Sci Rep. 2024 Feb 21;14(1):4257. doi: 10.1038/s41598-024-54651-3.
4
Identification and validation of oxeiptosis-associated lncRNAs and prognosis-related signature genes to predict the immune status in uterine corpus endometrial carcinoma.识别和验证与 oxeiptosis 相关的 lncRNAs 和预后相关的特征基因,以预测子宫体子宫内膜癌的免疫状态。
Aging (Albany NY). 2023 May 19;15(10):4236-4252. doi: 10.18632/aging.204726.
5
Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.构建新型坏死性凋亡相关 lncRNA 标志物预测食管癌预后。
BMC Gastroenterol. 2022 Jul 15;22(1):345. doi: 10.1186/s12876-022-02421-8.
6
m6A-related long noncoding RNAs predict prognosis and indicate therapeutic response in endometrial carcinoma.m6A 相关长链非编码 RNA 预测子宫内膜癌的预后并提示治疗反应。
J Clin Lab Anal. 2023 Jan;37(1):e24813. doi: 10.1002/jcla.24813. Epub 2022 Dec 16.
7
A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma.一种7-长链非编码RNA特征可预测子宫内膜癌的预后。
J Cell Biochem. 2019 Oct;120(10):18465-18477. doi: 10.1002/jcb.29164. Epub 2019 Jun 6.
8
Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs.基于铜死亡相关 lncRNAs 的子宫内膜癌预后特征构建和免疫治疗反应分析。
Comput Biol Med. 2023 Jun;159:106905. doi: 10.1016/j.compbiomed.2023.106905. Epub 2023 Apr 11.
9
Identification of an Immune-Related LncRNA Prognostic Signature in Uterine Corpus Endometrial Carcinoma Patients.识别子宫内膜癌患者免疫相关长链非编码 RNA 预后特征。
Clin Lab. 2021 Nov 1;67(11). doi: 10.7754/Clin.Lab.2021.210401.
10
A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.一种新型长链非编码 RNA 特征表达谱,用于预测子宫内膜癌患者的生存情况。
BMC Cancer. 2018 Jan 5;18(1):39. doi: 10.1186/s12885-017-3983-0.

引用本文的文献

1
Regulatory Effects of Endometriosis-Associated Genetic Variants: A Multi-Tissue eQTL Analysis.子宫内膜异位症相关基因变异的调控作用:多组织表达数量性状基因座分析
Diseases. 2025 Aug 6;13(8):248. doi: 10.3390/diseases13080248.
2
Single-cell and spatial atlas of glioblastoma heterogeneity: characterizing the + subtype and 's oncogenic role.胶质母细胞瘤异质性的单细胞和空间图谱:表征+亚型及其致癌作用。
Front Immunol. 2025 Jul 25;16:1614549. doi: 10.3389/fimmu.2025.1614549. eCollection 2025.
3
Integrative single-cell and spatial transcriptomics uncover ELK4-mediated mechanisms in + tumor cells driving gastric cancer progression, metabolic reprogramming, and immune evasion.

本文引用的文献

1
CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune Microenvironment.CDKN2B-AS1作为子宫内膜癌免疫微环境中一种新的预后相关分子标志物促进肿瘤恶性进展。
Front Cell Dev Biol. 2021 Oct 12;9:721676. doi: 10.3389/fcell.2021.721676. eCollection 2021.
2
A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer.一种稳健的低氧风险评分可预测膀胱癌的临床结局和肿瘤微环境免疫特征。
Front Immunol. 2021 Aug 13;12:725223. doi: 10.3389/fimmu.2021.725223. eCollection 2021.
3
Identification and validation of a five-lncRNA signature for predicting survival with targeted drug candidates in ovarian cancer.
整合单细胞和空间转录组学揭示ELK4介导的肿瘤细胞驱动胃癌进展、代谢重编程和免疫逃逸的机制。
Front Immunol. 2025 Jul 4;16:1591123. doi: 10.3389/fimmu.2025.1591123. eCollection 2025.
4
Single-cell technologies and spatial transcriptomics: decoding immune low - response states in endometrial cancer.单细胞技术与空间转录组学:解码子宫内膜癌中的免疫低反应状态
Front Immunol. 2025 Jul 2;16:1636483. doi: 10.3389/fimmu.2025.1636483. eCollection 2025.
5
Integrated multi-omics analysis reveals the immunotherapeutic significance of tumor cells with high FN1 expression in ovarian cancer.整合多组学分析揭示了 FN1 高表达肿瘤细胞在卵巢癌中的免疫治疗意义。
Front Mol Biosci. 2025 Jun 19;12:1611964. doi: 10.3389/fmolb.2025.1611964. eCollection 2025.
6
Single-cell insights into HNSCC tumor heterogeneity and programmed cell death pathways.对头颈部鳞状细胞癌肿瘤异质性和程序性细胞死亡途径的单细胞见解。
Transl Oncol. 2025 Apr;54:102341. doi: 10.1016/j.tranon.2025.102341. Epub 2025 Mar 10.
7
Discovering the Potential Role of the C2 DUSP2+ MCs Subgroup in Lung Adenocarcinoma.发现C2 DUSP2+肥大细胞亚群在肺腺癌中的潜在作用。
Transl Oncol. 2025 Apr;54:102295. doi: 10.1016/j.tranon.2025.102295. Epub 2025 Feb 26.
8
Prognostic implications of ERLncRNAs in ccRCC: a novel risk score model and its association with tumor mutation burden and immune microenvironment.ERLncRNAs在ccRCC中的预后意义:一种新型风险评分模型及其与肿瘤突变负荷和免疫微环境的关联
Discov Oncol. 2025 Feb 22;16(1):225. doi: 10.1007/s12672-025-01870-3.
9
Single-cell RNA sequencing revealed PPARG promoted osteosarcoma progression: based on osteoclast proliferation.单细胞RNA测序显示PPARG通过破骨细胞增殖促进骨肉瘤进展。
Front Immunol. 2025 Jan 28;15:1506225. doi: 10.3389/fimmu.2024.1506225. eCollection 2024.
10
Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategies.通过单细胞RNA测序表征高级别浆液性卵巢癌的肿瘤生物学和免疫微环境:对靶向和个性化免疫治疗策略的见解
Front Immunol. 2025 Jan 17;15:1500153. doi: 10.3389/fimmu.2024.1500153. eCollection 2024.
鉴定和验证五个 lncRNA 标志物,用于预测卵巢癌靶向候选药物治疗的生存情况。
Bioengineered. 2021 Dec;12(1):3263-3274. doi: 10.1080/21655979.2021.1946632.
4
Construction and Analysis of Survival-Associated Competing Endogenous RNA Network in Lung Adenocarcinoma.构建并分析肺腺癌中与生存相关的竞争性内源性 RNA 网络。
Biomed Res Int. 2021 Feb 11;2021:4093426. doi: 10.1155/2021/4093426. eCollection 2021.
5
RNA sequencing: new technologies and applications in cancer research.RNA 测序:癌症研究中的新技术和应用。
J Hematol Oncol. 2020 Dec 4;13(1):166. doi: 10.1186/s13045-020-01005-x.
6
A novel autophagy-related lncRNA prognostic risk model for breast cancer.一种新的与自噬相关的长链非编码 RNA 乳腺癌预后风险模型。
J Cell Mol Med. 2021 Jan;25(1):4-14. doi: 10.1111/jcmm.15980. Epub 2020 Nov 20.
7
Endometrial Cancer.子宫内膜癌
N Engl J Med. 2020 Nov 19;383(21):2053-2064. doi: 10.1056/NEJMra1514010.
8
Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.鉴定和验证与免疫相关的长链非编码 RNA 标志物,用于预测膀胱癌患者的预后。
Int Immunopharmacol. 2021 Jan;90:107146. doi: 10.1016/j.intimp.2020.107146. Epub 2020 Nov 11.
9
Cancer immunotherapy via targeted TGF-β signalling blockade in T cells.通过靶向T细胞中的转化生长因子-β信号传导阻滞进行癌症免疫治疗。
Nature. 2020 Nov;587(7832):121-125. doi: 10.1038/s41586-020-2850-3. Epub 2020 Oct 21.
10
Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation.剪接因子 SF3B1 通过调节 KSR2 RNA 的成熟促进子宫内膜癌的进展。
Cell Death Dis. 2020 Oct 10;11(10):842. doi: 10.1038/s41419-020-03055-y.